These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 7511361)

  • 1. Effects of antifungal therapy on inflammation, sterilization, and histology in experimental Candida albicans meningitis.
    Jafari HS; Sáez-Llorens X; Severien C; Parras F; Friedland I; Rinderknecht S; Ehrett S; Olsen KD; Abramowsky C; McCracken GH
    Antimicrob Agents Chemother; 1994 Jan; 38(1):83-9. PubMed ID: 7511361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis due to Candida albicans.
    Louie A; Liu W; Miller DA; Sucke AC; Liu QF; Drusano GL; Mayers M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2831-40. PubMed ID: 10582868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of amphotericin B lipid complex in a rabbit model of coccidioidal meningitis.
    Capilla J; Clemons KV; Sobel RA; Stevens DA
    J Antimicrob Chemother; 2007 Sep; 60(3):673-6. PubMed ID: 17646202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of CG(3)R(6)TAT nanoparticles self-assembled from a novel antimicrobial peptide for the treatment of Candida albicans meningitis in rabbits.
    Xu K; Wang H; Liu L; Xu W; Sheng J; Fan W; Yang YY; Li L
    Chemotherapy; 2011; 57(5):417-25. PubMed ID: 22024735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of LY303366, a novel echinocandin B, in experimental disseminated candidiasis in rabbits.
    Petraitiene R; Petraitis V; Groll AH; Candelario M; Sein T; Bell A; Lyman CA; McMillian CL; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 1999 Sep; 43(9):2148-55. PubMed ID: 10471556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rabbit model of Candida albicans biofilm infection: liposomal amphotericin B antifungal lock therapy.
    Schinabeck MK; Long LA; Hossain MA; Chandra J; Mukherjee PK; Mohamed S; Ghannoum MA
    Antimicrob Agents Chemother; 2004 May; 48(5):1727-32. PubMed ID: 15105127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of intra-abdominal abscesses caused by Candida albicans with antifungal agents and recombinant murine granulocyte colony-stimulating factor.
    Vonk AG; Netea MG; van Krieken JH; Verweij PE; van der Meer JW; Kullberg BJ
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3688-93. PubMed ID: 14638466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative efficacies of cilofungin (Ly121019) and amphotericin B against disseminated Candida albicans infection in normal and granulocytopenic mice.
    Khardori N; Nguyen H; Stephens LC; Kalvakuntla L; Rosenbaum B; Bodey GP
    Antimicrob Agents Chemother; 1993 Apr; 37(4):729-36. PubMed ID: 8494367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
    Chemlal K; Saint-Julien L; Joly V; Farinotti R; Seta N; Yeni P; Carbon C
    Antimicrob Agents Chemother; 1996 Jan; 40(1):263-6. PubMed ID: 8787921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between fluconazole and amphotericin B in mice with systemic infection due to fluconazole-susceptible or -resistant strains of Candida albicans.
    Louie A; Banerjee P; Drusano GL; Shayegani M; Miller MH
    Antimicrob Agents Chemother; 1999 Dec; 43(12):2841-7. PubMed ID: 10582869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid and plasma (1-->3)-beta-D-glucan as surrogate markers for detection and monitoring of therapeutic response in experimental hematogenous Candida meningoencephalitis.
    Petraitiene R; Petraitis V; Hope WW; Mickiene D; Kelaher AM; Murray HA; Mya-San C; Hughes JE; Cotton MP; Bacher J; Walsh TJ
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4121-9. PubMed ID: 18779361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
    Nolte FS; Parkinson T; Falconer DJ; Dix S; Williams J; Gilmore C; Geller R; Wingard JR
    Antimicrob Agents Chemother; 1997 Jan; 41(1):196-9. PubMed ID: 8980781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of fluconazole and amphotericin B for treatment of disseminated candidiasis and endophthalmitis in rabbits.
    Filler SG; Crislip MA; Mayer CL; Edwards JE
    Antimicrob Agents Chemother; 1991 Feb; 35(2):288-92. PubMed ID: 2024963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
    Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE
    Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
    Van t Wout JW; Mattie H; van Furth R
    Antimicrob Agents Chemother; 1989 Feb; 33(2):147-51. PubMed ID: 2541654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
    Sorensen KN; Sobel RA; Clemons KV; Calderon L; Howell KJ; Irani PR; Pappagianis D; Williams PL; Stevens DA
    Antimicrob Agents Chemother; 2000 Nov; 44(11):3087-91. PubMed ID: 11036027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifungal activity of amphotericin B, fluconazole, and voriconazole in an in vitro model of Candida catheter-related bloodstream infection.
    Lewis RE; Kontoyiannis DP; Darouiche RO; Raad II; Prince RA
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3499-505. PubMed ID: 12384356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
    Witt MD; Imhoff T; Li C; Bayer AS
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2030-2. PubMed ID: 8239628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of amphotericin B and fluconazole on the extracellular and intracellular growth of Candida albicans.
    van Etten EW; van de Rhee NE; van Kampen KM; Bakker-Woudenberg IA
    Antimicrob Agents Chemother; 1991 Nov; 35(11):2275-81. PubMed ID: 1804000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.